Overview

Miltefosine for Brazilian Visceral Leishmaniasis

Status:
Terminated
Trial end date:
2007-10-01
Target enrollment:
Participant gender:
Summary
Miltefosine will be administered to Brazilian patients with kala azar
Phase:
Phase 1/Phase 2
Details
Lead Sponsor:
AB Foundation
Collaborator:
AEterna Zentaris
Treatments:
Miltefosine